[PDF] Top 20 Multiple myeloma in the very elderly patient: challenges and solutions

... Diagnosing myeloma (Table 2) requires the demonstra- tion of a clonal population of plasma cells either within the bone marrow, or less commonly, within a bony or extramed- ullary ...the elderly; however, ... See full document

... not very informative for clinical decision ...between elderly and younger subjects that may affect treatment tolerance: the decline in normal organ function can lead to different drug metabolism and ... See full document

... the elderly group than the younger group, in terms of both time to progression and OS (12 vs 8 months and 16 vs 12 months, respectively), and considering the rate of serious side effects ... See full document

... in elderly patients with AF and coronary artery disease (CAD) is ...the elderly, the duration of this therapy should not last more than 4 weeks, and bare metal stent should be ... See full document

... the elderly population. Elderly patients are a vulnerable population at increased risk for treatment- related toxicity secondary to medical comorbidities and geriatric ...fit elderly and modify ... See full document

... context, elderly individuals frequently take drugs (eg, thiazide diuretics, selective sero- tonin reuptake inhibitors [SSRIs], serotonin–norepinephrine reuptake inhibitors [SNRIs], nonsteroidal anti-inflammatory ... See full document

... the patient was in a state of poor oral fluid intake. The patient developed hypernatremia and hyperchloremia, with a peak serum sodium and chloride levels of 183 mmol/L and 153 mmol/L, respectively, at the ... See full document

... Return to function should be regarded as a key outcome for elderly patients. With life expectancy of an additional 20–30 years for an average 65-year-old person, the cost of increased dependency can be massive. ... See full document

... treated, including 233 over the age of 65 years. The signifi cant toxicity of the high-dose dexamethasone regimen was fully confi rmed but the good news was the modest toxicity of the low-dose dexamethasone regimen. ... See full document

... Multiple myeloma, a disease of elderly, is extremely rare in those about 30 years of ...A patient with MM diagnosed at age 27 is ...of multiple myeloma. Our patient was ... See full document

... Serum samples from patients were collected before starting any myeloma-related treatment. Sera, collected from patients and controls, were aliquoted into separate vials and stored at −70°C. All assays were ... See full document

... the patient was ventilated under tracheostomy, totally dependent on mechanical ventilation, persistently Glasgow ...the patient presented positive for both DNA (HHV-1 and HHV-2), confirming the diagnosis of ... See full document

... A 64-year-old male with chronic low back pain presented to the emergency department with a new onset, severe mid back pain radiating to bilateral shoulders. CT scan, per- formed to rule out aortic dissection, ... See full document

... As per data available over three-quarters of the world population relies mainly on plants and plant extracts for their health care needs. More than 30% of the entire plant species, at one time or other were used for ... See full document

... a patient with paraparesis and backache, multiple myeloma should be considered as a differential ...for multiple myeloma multiple myeloma will lead to delays in diagnosis ... See full document

... Bisphosphonate-related ONJ was originally believed to be a direct, noninfectious complication of bisphosphonate therapy. However, recent histological and microbiological data strongly support that Actinomyces play a ... See full document

... whether patient information were given (either information lea fl et or verbal advice), (2) whether the patient had satisfactory dental check with a date documented on the form, (3) a table of blood test ... See full document

... The turnover rates of radioactively labeled beta and gamma globulins in a hypergammaglobulinemic multiple myeloma patient were compared by the conventional serum and urinary excretion me[r] ... See full document

... One (3.8%) of the patients on stage IIIB disease of MM underwent ASCT. However, he died following post- transplantation relapse 2 years thereafter. Stem-cell trans- plantation involves eliminating a patient’s hemopoeitic ... See full document

... Abstract: Multiple myeloma (MM) is a B-cell malignancy characterized by clonal expansion of plasma cells within the bone marrow, the presence of a serum and/or urine monoclonal protein, lytic bone lesions, ... See full document